Page 36 - Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine

Yu B et al. MSC-derived EVs in ocular diseases

70 Pezzullo L, Streatfeild J, Simkiss P, Shickle D. The economic impact of sight loss and blindness in the UK
adult population. BMC Health Serv Res 2018; 18: 63 [PMID: 29382329 DOI:
10.1186/s12913-018-2836-0]
71 Zhang W, Wang Y, Kong Y. Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to
Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1. Invest Ophthalmol Vis
Sci 2019; 60: 294-303 [PMID: 30657854 DOI: 10.1167/iovs.18-25617]
72 Safwat A, Sabry D, Ragiae A, Amer E, Mahmoud RH, Shamardan RM. Adipose mesenchymal stem cells-
derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits. J Circ
Biomark 2018; 7: 1849454418807827 [PMID: 30397416 DOI: 10.1177/1849454418807827]
73 Jiang Y, Zhang Y, Zhang L, Wang M, Zhang X, Li X. Therapeutic effect of bone marrow mesenchymal
stem cells on laser-induced retinal injury in mice. Int J Mol Sci 2014; 15: 9372-9385 [PMID: 24871366
DOI: 10.3390/ijms15069372]
74 Yu B, Shao H, Su C, Jiang Y, Chen X, Bai L, Zhang Y, Li Q, Zhang X, Li X. Exosomes derived from
MSCs ameliorate retinal laser injury partially by inhibition of MCP-1. Sci Rep 2016; 6: 34562 [PMID:
27686625 DOI: 10.1038/srep34562]
75 Ma M, Li B, Zhang M, Zhou L, Yang F, Ma F, Shao H, Li Q, Li X, Zhang X. Therapeutic effects of
mesenchymal stem cell-derived exosomes on retinal detachment. Exp Eye Res 2020; 191: 107899 [PMID:
31866431 DOI: 10.1016/j.exer.2019.107899]
76 Mathew B, Ravindran S, Liu X, Torres L, Chennakesavalu M, Huang CC, Feng L, Zelka R, Lopez J,
Sharma M, Roth S. Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion.
Biomaterials 2019; 197: 146-160 [PMID: 30654160 DOI: 10.1016/j.biomaterials.2019.01.016]
77 Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protective Effect of
Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia.
Curr Eye Res 2017; 42: 1358-1367 [PMID: 28636406 DOI: 10.1080/02713683.2017.1319491]
78 Antimisiaris SG, Mourtas S, Marazioti A. Exosomes and Exosome-Inspired Vesicles for Targeted Drug
Delivery. Pharmaceutics 2018; 10 [PMID: 30404188 DOI: 10.3390/pharmaceutics10040218]
79 Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia
SM, Parati E, Bernardo ME, Muraca M, Alessandri G, Bondiolotti G, Pessina A. Paclitaxel is incorporated
by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach
for drug delivery. J Control Release 2014; 192: 262-270 [PMID: 25084218 DOI:
10.1016/j.jconrel.2014.07.042]
80 Zhang L, Song Y, Chen L, Li D, Feng H, Lu Z, Fan T, Chen Z, Livingston MJ, Geng Q. MiR-20a-
containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia/reperfusion
injury. J Cell Physiol 2020; 235: 3698-3710 [PMID: 31566731 DOI: 10.1002/jcp.29264]
81 Chen S, Tang Y, Liu Y, Zhang P, Lv L, Zhang X, Jia L, Zhou Y. Exosomes derived from miR-375-
overexpressing human adipose mesenchymal stem cells promote bone regeneration. Cell Prolif 2019; 52:
e12669 [PMID: 31380594 DOI: 10.1111/cpr.12669]

WJSC https://www.wjgnet.com 187 March 26, 2020 Volume 12 Issue 3